Agile Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Agile Therapeutics

Access the complete profile.

Agile Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	500 College Rd E Ste 310 Princeton, NJ 08540

Note: Revenues for privately held companies are statistical evaluations.


Agile Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Agile Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Agile Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Agile Therapeutics Annual Revenue and Growth Rate

Agile Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Agile Therapeutics's revenues are gauged from an analysis of company filings.

Agile Therapeutics's Income Statement (based on Industry Averages)

Agile Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Agile Therapeutics is developing and marketing. Agile Therapeutics doesn't have any recent trademark applications, indicating Agile Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TWIRLA contraceptives	01/03/2012
LCURVE Transdermal patches used for contraception	01/03/2012

See all trademarks and details in the Full Report.

Market Share of Agile Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Agile Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Agile Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NOVO NORDISK PHARMA	Plainsboro, NJ	100
SUN PHARMACEUTICAL INDUSTRIES	Princeton, NJ	21
GENMAB US	Plainsboro, NJ	12
KYOWA KIRIN	Princeton, NJ	10
ACTELION PHARMACEUTICALS US	Titusville, NJ	2
E R SQUIBB & SONS	Princeton, NJ	2

Future Competition: Agile Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Agile Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)